Uli Bialucha
Chief Tech/Sci/R&D Officer presso XILIO THERAPEUTICS, INC.
Profilo
Uli Bialucha is currently the Chief Scientific Officer at Xilio Therapeutics, Inc. Previously, Uli held the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc. Uli completed their undergraduate degree at the University of Sussex and obtained a doctorate from University College London.
Posizioni attive di Uli Bialucha
| Società | Posizione | Inizio |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Precedenti posizioni note di Uli Bialucha
| Società | Posizione | Fine |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Uli Bialucha
| University of Sussex | Undergraduate Degree |
| University College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Uli Bialucha
